Respiratory viral infections in children with asthma: do they matter and can we prevent them?

Hamid Ahanchian, Carmen M Jones, Yueh-sheng Chen, Peter D Sly, Hamid Ahanchian, Carmen M Jones, Yueh-sheng Chen, Peter D Sly

Abstract

Background: Asthma is a major public health problem with a huge social and economic burden affecting 300 million people worldwide. Viral respiratory infections are the major cause of acute asthma exacerbations and may contribute to asthma inception in high risk young children with susceptible genetic background. Acute exacerbations are associated with decreased lung growth or accelerated loss of lung function and, as such, add substantially to both the cost and morbidity associated with asthma.

Discussion: While the importance of preventing viral infection is well established, preventive strategies have not been well explored. Good personal hygiene, hand-washing and avoidance of cigarette smoke are likely to reduce respiratory viral infections. Eating a healthy balanced diet, active probiotic supplements and bacterial-derived products, such as OM-85, may reduce recurrent infections in susceptible children. There are no practical anti-viral therapies currently available that are suitable for widespread use.

Summary: Hand hygiene is the best measure to prevent the common cold. A healthy balanced diet, active probiotic supplements and immunostimulant OM-85 may reduce recurrent infections in asthmatic children.

References

    1. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–478. doi: 10.1111/j.1398-9995.2004.00526.x.
    1. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM, Wright AL, Martinez FD. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet. 1999;354(9178):541–545. doi: 10.1016/S0140-6736(98)10321-5.
    1. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman B. Respiratory syncytial virus bronchiolitis in infancy is an important risk factor for asthma and allergy at age 7. Am J Respir Crit Care Med. 2000;161(5):1501–1507.
    1. Kusel MM, de Klerk NH, Kebadze T, Vohma V, Holt PG, Johnston SL, Sly PD. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy Clin Immunol. 2007;119(5):1105–1110. doi: 10.1016/j.jaci.2006.12.669.
    1. Sly PD, Kusel M, Holt PG. Do early-life viral infections cause asthma? J Allergy Clin Immunol. 2010;125(6):1202–1205. doi: 10.1016/j.jaci.2010.01.024.
    1. Lemanske RF Jr, Jackson DJ, Gangnon RE, Evans MD, Li Z, Shult PA, Kirk CJ, Reisdorf E, Roberg KA, Anderson EL. et al.Rhinovirus illnesses during infancy predict subsequent childhood wheezing. J Allergy Clin Immunol. 2005;116(3):571–577. doi: 10.1016/j.jaci.2005.06.024.
    1. Jackson DJ, Gangnon RE, Evans MD, Roberg KA, Anderson EL, Pappas TE, Printz MC, Lee WM, Shult PA, Reisdorf E. et al.Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178(7):667–672. doi: 10.1164/rccm.200802-309OC.
    1. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307(6910):982–986. doi: 10.1136/bmj.307.6910.982.
    1. Mallia P, Johnston SL. How viral infections cause exacerbation of airway diseases. Chest. 2006;130(4):1203–1210. doi: 10.1378/chest.130.4.1203.
    1. Kling S, Donninger H, Williams Z, Vermeulen J, Weinberg E, Latiff K, Ghildyal R, Bardin P. Persistence of rhinovirus RNA after asthma exacerbation in children. Clin Exp Allergy. 2005;35(5):672–678. doi: 10.1111/j.1365-2222.2005.02244.x.
    1. Murray CS, Poletti G, Kebadze T, Morris J, Woodcock A, Johnston SL, Custovic A. Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children. Thorax. 2006;61(5):376–382. doi: 10.1136/thx.2005.042523.
    1. Heymann PW, Carper HT, Murphy DD, Platts-Mills TA, Patrie J, McLaughlin AP, Erwin EA, Shaker MS, Hellems M, Peerzada J. et al.Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing. J Allergy Clin Immunol. 2004;114(2):239–247. doi: 10.1016/j.jaci.2004.04.006.
    1. Wark PA, Johnston SL, Moric I, Simpson JL, Hensley MJ, Gibson PG. Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma. Eur Respir J. 2002;19(1):68–75. doi: 10.1183/09031936.02.00226302.
    1. Holtzman MJ, Byers DE, Benoit LA, Battaile JT, You Y, Agapov E, Park C, Grayson MH, Kim EY, Patel AC. Immune pathways for translating viral infection into chronic airway disease. Adv Immunol. 2009;102:245–276.
    1. Holtzman MJ, Patel DA, Zhang Y, Patel AC. Host epithelial-viral interactions as cause and cure for asthma. Curr Opin Immunol. 2011;23(4):487–494. doi: 10.1016/j.coi.2011.05.010.
    1. Holgate ST. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol. 2007;28(6):248–251. doi: 10.1016/j.it.2007.04.007.
    1. Holgate ST. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev. 2011;242(1):205–219. doi: 10.1111/j.1600-065X.2011.01030.x.
    1. Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol. 2010;11(4):289–293. doi: 10.1038/ni.1852.
    1. Fraenkel DJ, Bardin PG, Sanderson G, Lampe F, Johnston SL, Holgate ST. Lower airways inflammation during rhinovirus colds in normal and in asthmatic subjects. Am J Respir Crit Care Med. 1995;151(3 Pt 1):879–886.
    1. Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol. 2010;3(1):69–80. doi: 10.1038/mi.2009.109.
    1. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, Holgate ST, Davies DE. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med. 2005;201(6):937–947. doi: 10.1084/jem.20041901.
    1. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, Kebadze T, Mallia P, Stanciu LA, Parker HL. et al.Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med. 2006;12(9):1023–1026. doi: 10.1038/nm1462.
    1. Gill MA, Bajwa G, George TA, Dong CC, Dougherty II, Jiang N, Gan VN, Gruchalla RS. Counterregulation between the FcepsilonRI pathway and antiviral responses in human plasmacytoid dendritic cells. J Immunol. 2010;184(11):5999–6006. doi: 10.4049/jimmunol.0901194.
    1. Tulic MK, Hurrelbrink RJ, Prele CM, Laing IA, Upham JW, Le Souef P, Sly PD, Holt PG. TLR4 polymorphisms mediate impaired responses to respiratory syncytial virus and lipopolysaccharide. J Immunol. 2007;179(1):132–140.
    1. Holt PG, Sly PD. Interaction between adaptive and innate immune pathways in the pathogenesis of atopic asthma: operation of a lung/bone marrow axis. Chest. 2011;139(5):1165–1171. doi: 10.1378/chest.10-2397.
    1. Hales BJ, Chai LY, Elliot CE, Pearce LJ, Zhang G, Heinrich TK, Smith WA, Kusel MM, Holt PG, Sly PD. et al.Antibacterial antibody responses associated with the development of asthma in house dust mite-sensitised and non-sensitised children. Thorax. 2011;67(4):321–327.
    1. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol. 2011;128(6):1165–1174. doi: 10.1016/j.jaci.2011.10.024.
    1. O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009;179(1):19–24.
    1. Weiss ST, Van NML, Zeiger RS. Relationship between increased airway responsiveness and asthma severity in the childhood asthma management program. Am J Respir Crit Care Med. 2000;162(1):50–56.
    1. Sears MR, Johnston NW. Understanding the September asthma epidemic. J Allergy Clin Immunol. 2007;120(3):526–529. doi: 10.1016/j.jaci.2007.05.047.
    1. Forno E, Celedon JC. Predicting asthma exacerbations in children. Curr Opin Pulm Med. 2012;18(1):63–69. doi: 10.1097/MCP.0b013e32834db288.
    1. Busse WW, Lemanske RF Jr, Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet. 2010;376(9743):826–834. doi: 10.1016/S0140-6736(10)61380-3.
    1. Jackson DJ, Johnston SL. The role of viruses in acute exacerbations of asthma. J Allergy Clin Immunol. 2010;125(6):1178–1187. doi: 10.1016/j.jaci.2010.04.021. quiz 1188–1179.
    1. Jackson DJ, Sykes A, Mallia P, Johnston SL. Asthma exacerbations: origin, effect, and prevention. J Allergy Clin Immunol. 2011;128(6):1165–1174. doi: 10.1016/j.jaci.2011.10.024.
    1. Johnston NW, Johnston SL, Duncan JM, Greene JM, Kebadze T, Keith PK, Roy M, Waserman S, Sears MR. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol. 2005;115(1):132–138. doi: 10.1016/j.jaci.2004.09.025.
    1. Dulek DE, Peebles RS Jr. Viruses and asthma. Biochim Biophys Acta. 2011;1810(11):1080–1090. doi: 10.1016/j.bbagen.2011.01.012.
    1. Wu P, Hartert TV. Evidence for a causal relationship between respiratory syncytial virus infection and asthma. Expert Rev Anti Infect Ther. 2011;9(9):731–745. doi: 10.1586/eri.11.92.
    1. Gern JE. Rhinovirus and the initiation of asthma. Curr Opin Allergy Clin Immunol. 2009;9(1):73–78. doi: 10.1097/ACI.0b013e32831f8f1b.
    1. Wu P, Dupont WD, Griffin MR, Carroll KN, Mitchel EF, Gebretsadik T, Hartert TV. Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med. 2008;178(11):1123–1129. doi: 10.1164/rccm.200804-579OC.
    1. Simoes EA, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick L, Groothuis JR. Palivizumab Long-Term Respiratory Outcomes Study G. The effect of respiratory syncytial virus on subsequent recurrent wheezing in atopic and nonatopic children. J Allergy Clin Immunol. 2010;126(2):256–262. doi: 10.1016/j.jaci.2010.05.026.
    1. Holt PG, Upham JW, Sly PD. Contemporaneous maturation of immunologic and respiratory functions during early childhood: implications for development of asthma prevention strategies. J Allergy Clin Immunol. 2005;116(1):16–24. doi: 10.1016/j.jaci.2005.04.017. quiz 25.
    1. Jackson DJ. The role of rhinovirus infections in the development of early childhood asthma. Curr Opin Allergy Clin Immunol. 2010;10(2):133–138. doi: 10.1097/ACI.0b013e3283352f7c.
    1. Huang YJ, Lynch SV. The emerging relationship between the airway microbiota and chronic respiratory disease: clinical implications. Expert Rev Respir Med. 2011;5(6):809–821. doi: 10.1586/ers.11.76.
    1. Brar T, Nagaraj S, Mohapatra S. Microbes and asthma: the missing cellular and molecular links. Curr Opin Pulm Med. 2012;18(1):14–22. doi: 10.1097/MCP.0b013e32834dccc0.
    1. Bisgaard H, Hermansen MN, Bonnelykke K, Stokholm J, Baty F, Skytt NL, Aniscenko J, Kebadze T, Johnston SL. Association of bacteria and viruses with wheezy episodes in young children: prospective birth cohort study. BMJ. 2010;341:c4978. doi: 10.1136/bmj.c4978.
    1. Hishiki H, Ishiwada N, Fukasawa C, Abe K, Hoshino T, Aizawa J, Ishikawa N, Kohno Y. Incidence of bacterial coinfection with respiratory syncytial virus bronchopulmonary infection in pediatric inpatients. J Infect Chemother. 2011;17(1):87–90. doi: 10.1007/s10156-010-0097-x.
    1. Rollinger JM, Schmidtke M. The human rhinovirus: human-pathological impact, mechanisms of antirhinoviral agents, and strategies for their discovery. Med Res Rev. 2011;31(1):42–92. doi: 10.1002/med.20176.
    1. Peltola V, Waris M, Osterback R, Susi P, Ruuskanen O, Hyypia T. Rhinovirus transmission within families with children: incidence of symptomatic and asymptomatic infections. J Infect Dis. 2008;197(3):382–389. doi: 10.1086/525542.
    1. Jartti T, Lehtinen P, Vuorinen T, Koskenvuo M, Ruuskanen O. Persistence of rhinovirus and enterovirus RNA after acute respiratory illness in children. J Med Virol. 2004;72(4):695–699. doi: 10.1002/jmv.20027.
    1. Pappas DE, Hendley JO. The common cold and decongestant therapy. Pediatr Rev. 2011;32(2):47–54. doi: 10.1542/pir.32-2-47. quiz 55.
    1. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, van Driel ML, Nair S, Jones MA, Thorning S, Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2011. p. CD006207.
    1. Stewardson A, Allegranzi B, Sax H, Kilpatrick C, Pittet D. Back to the future: rising to the Semmelweis challenge in hand hygiene. Future Microbiol. 2011;6(8):855–876. doi: 10.2217/fmb.11.66.
    1. Luby SP, Agboatwalla M, Feikin DR, Painter J, Billhimer W, Altaf A, Hoekstra RM. Effect of handwashing on child health: a randomised controlled trial. Lancet. 2005;366(9481):225–233. doi: 10.1016/S0140-6736(05)66912-7.
    1. Lee GM, Salomon JA, Friedman JF, Hibberd PL, Ross-Degnan D, Zasloff E, Bediako S, Goldmann DA. Illness transmission in the home: a possible role for alcohol-based hand gels. Pediatrics. 2005;115(4):852–860. doi: 10.1542/peds.2004-0856.
    1. Sandora TJ, Taveras EM, Shih MC, Resnick EA, Lee GM, Ross-Degnan D, Goldmann DA. A randomized, controlled trial of a multifaceted intervention including alcohol-based hand sanitizer and hand-hygiene education to reduce illness transmission in the home. Pediatrics. 2005;116(3):587–594. doi: 10.1542/peds.2005-0199.
    1. Master D, Hess Longe SH, Dickson H. Scheduled hand washing in an elementary school population. Fam Med. 1997;29(5):336–339.
    1. Carabin H, Gyorkos TW, Soto JC, Joseph L, Payment P, Collet JP. Effectiveness of a training program in reducing infections in toddlers attending day care centers. Epidemiology. 1999;10(3):219–227. doi: 10.1097/00001648-199905000-00005.
    1. Roberts L, Smith W, Jorm L, Patel M, Douglas RM, McGilchrist C. Effect of infection control measures on the frequency of upper respiratory infection in child care: a randomized, controlled trial. Pediatrics. 2000;105(4 Pt 1):738–742.
    1. Talaat M, Afifi S, Dueger E, El-Ashry N, Marfin A, Kandeel A, Mohareb E, El-Sayed N. Effects of hand hygiene campaigns on incidence of laboratory-confirmed influenza and absenteeism in schoolchildren, Cairo, Egypt. Emerg Infect Dis. 2011;17(4):619–625. doi: 10.3201/eid1704.101353.
    1. Turner RB, Fuls JL, Rodgers ND, Goldfarb HB, Lockhart LK, Aust LB. A randomized trial of the efficacy of hand disinfection for prevention of rhinovirus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2012;54(10):1422–1426.
    1. Cowling BJ, Zhou Y, Ip DK, Leung GM, Aiello AE. Face masks to prevent transmission of influenza virus: a systematic review. Epidemiol Infect. 2010;138(4):449–456. doi: 10.1017/S0950268809991658.
    1. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11(9):607–615. doi: 10.1038/nri3041.
    1. Matthews CE, Ockene IS, Freedson PS, Rosal MC, Merriam PA, Hebert JR. Moderate to vigorous physical activity and risk of upper-respiratory tract infection. Med Sci Sports Exerc. 2002;34(8):1242–1248. doi: 10.1097/00005768-200208000-00003.
    1. Nieman DC, Henson DA, Austin MD, Sha W. Upper respiratory tract infection is reduced in physically fit and active adults. Br J Sports Med. 2011;45(12):987–992. doi: 10.1136/bjsm.2010.077875.
    1. Fahlman MM, Engels HJ. Mucosal IgA and URTI in American college football players: a year longitudinal study. Med Sci Sports Exerc. 2005;37(3):374–380. doi: 10.1249/01.MSS.0000155432.67020.88.
    1. Lucas SR, Platts-Mills TA. Physical activity and exercise in asthma: relevance to etiology and treatment. J Allergy Clin Immunol. 2005;115(5):928–934. doi: 10.1016/j.jaci.2005.01.033.
    1. Gleeson M, Bishop N, Oliveira M, McCauley T, Tauler P, Muhamad AS. Respiratory infection risk in athletes: association with antigen-stimulated IL-10 production and salivary IgA secretion. Scand J Med Sci Sports. 2011;22(3):410–417.
    1. Barrett B, Hayney MS, Muller D, Rakel D, Ward A, Obasi CN, Brown R, Zhang Z, Zgierska A, Gern J. et al.Meditation or Exercise for Preventing Acute Respiratory Infection: A Randomized Controlled Trial. Ann Fam Med. 2012;10(4):337–346. doi: 10.1370/afm.1376.
    1. Brehm JM, Celedon JC, Soto-Quiros ME, Avila L, Hunninghake GM, Forno E, Laskey D, Sylvia JS, Hollis BW, Weiss ST. et al.Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009;179(9):765–771. doi: 10.1164/rccm.200808-1361OC.
    1. Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, Weiss ST, Litonjua AA. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010;126(1):52–58. doi: 10.1016/j.jaci.2010.03.043. e55.
    1. Issazadeh-Navikas S, Teimer R, Bockermann R. Influence of dietary components on regulatory T cells. Mol Med. 2011;18(1):95–110.
    1. Singh M, Das RR. Zinc for the common cold. Cochrane Database Syst Rev. 2011. p. CD001364.
    1. Lissiman E, Bhasale AL, Cohen M. Garlic for the common cold. Cochrane Database Syst Rev. 2009. p. CD006206.
    1. Linde K, Barrett B, Wolkart K, Bauer R, Melchart D. Echinacea for preventing and treating the common cold. Cochrane Database Syst Rev. 2006. p. CD000530.
    1. Seida JK, Durec T, Kuhle S. North American (Panax quinquefolius) and Asian Ginseng (Panax ginseng) Preparations for Prevention of the Common Cold in Healthy Adults: A Systematic Review. Evid Based Complement Alternat Med. 2011;2011:282151.
    1. McCloud E, Papoutsakis C. A medical nutrition therapy primer for childhood asthma: current and emerging perspectives. J Am Diet Assoc. 2011;111(7):1052–1064. doi: 10.1016/j.jada.2011.04.005.
    1. Levy ML, Thomas M, Small I, Pearce L, Pinnock H, Stephenson P. Summary of the 2008 BTS/SIGN British Guideline on the management of asthma. Prim Care Respir J. 2009;18(Suppl 1):S1–S16.
    1. Turner RB, Bauer R, Woelkart K, Hulsey TC, Gangemi JD. An evaluation of Echinacea angustifolia in experimental rhinovirus infections. N Engl J Med. 2005;353(4):341–348. doi: 10.1056/NEJMoa044441.
    1. Douglas RM, Hemila H, Chalker E, Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2007. p. CD000980.
    1. Labbok MH, Clark D, Goldman AS. Breastfeeding: maintaining an irreplaceable immunological resource. Nat Rev Immunol. 2004;4(7):565–572. doi: 10.1038/nri1393.
    1. Abrahams SW, Labbok MH. Breastfeeding and otitis media: a review of recent evidence. Curr Allergy Asthma Rep. 2011;11(6):508–512. doi: 10.1007/s11882-011-0218-3.
    1. Torres-Borrego J, Moreno-Solis G, Molina-Teran AB. Diet for the prevention of asthma and allergies in early childhood: Much ado about something? Allergol Immunopathol (Madr) 2012;40(4):244–252. doi: 10.1016/j.aller.2011.12.006.
    1. Besedovsky L, Lange T, Born J. Sleep and immune function. Pflugers Arch. 2012;463(1):121–137. doi: 10.1007/s00424-011-1044-0.
    1. Lange T, Dimitrov S, Born J. Effects of sleep and circadian rhythm on the human immune system. Ann N Y Acad Sci. 2010;1193:48–59. doi: 10.1111/j.1749-6632.2009.05300.x.
    1. Cohen S, Doyle WJ, Alper CM, Janicki-Deverts D, Turner RB. Sleep habits and susceptibility to the common cold. Arch Intern Med. 2009;169(1):62–67. doi: 10.1001/archinternmed.2008.505.
    1. Patel SR, Malhotra A, Gao X, Hu FB, Neuman MI, Fawzi WW. A prospective study of sleep duration and pneumonia risk in women. Sleep. 2012;35(1):97–101.
    1. Treyster Z, Gitterman B. Second hand smoke exposure in children: environmental factors, physiological effects, and interventions within pediatrics. Rev Environ Health. 2011;26(3):187–195.
    1. Huttunen R, Heikkinen T, Syrjanen J. Smoking and the outcome of infection. J Intern Med. 2011;269(3):258–269. doi: 10.1111/j.1365-2796.2010.02332.x.
    1. Ciencewicki J, Jaspers I. Air pollution and respiratory viral infection. Inhal Toxicol. 2007;19(14):1135–1146. doi: 10.1080/08958370701665434.
    1. Rabinovitch N, Silveira L, Gelfand EW, Strand M. The response of children with asthma to ambient particulate is modified by tobacco smoke exposure. Am J Respir Crit Care Med. 2011;184(12):1350–1357. doi: 10.1164/rccm.201010-1706OC.
    1. Li JS, Peat JK, Xuan W, Berry G. Meta-analysis on the association between environmental tobacco smoke (ETS) exposure and the prevalence of lower respiratory tract infection in early childhood. Pediatr Pulmonol. 1999;27(1):5–13. doi: 10.1002/(SICI)1099-0496(199901)27:1<5::AID-PPUL3>;2-5.
    1. Aronson MD, Weiss ST, Ben RL, Komaroff AL. Association between cigarette smoking and acute respiratory tract illness in young adults. Jama. 1982;248(2):181–183. doi: 10.1001/jama.1982.03330020025023.
    1. Venarske DL, Busse WW, Griffin MR, Gebretsadik T, Shintani AK, Minton PA, Peebles RS, Hamilton R, Weisshaar E, Vrtis R. et al.The relationship of rhinovirus-associated asthma hospitalizations with inhaled corticosteroids and smoking. J Infect Dis. 2006;193(11):1536–1543. doi: 10.1086/503809.
    1. Rabinovitch N, Reisdorph N, Silveira L, Gelfand EW. Urinary leukotriene E levels identify children with tobacco smoke exposure at risk for asthma exacerbation. J Allergy Clin Immunol. 2011;128(2):323–327. doi: 10.1016/j.jaci.2011.05.035.
    1. Fioramonti J, Theodorou V, Bueno L. Probiotics: what are they? What are their effects on gut physiology? Best Pract Res Clin Gastroenterol. 2003;17(5):711–724. doi: 10.1016/S1521-6918(03)00075-1.
    1. Caramia G. Metchnikoff and the centenary of probiotics: an update of their use in gastroenteric pathology during the age of development. Minerva Pediatr. 2008;60(6):1417–1435.
    1. Yoo J, Tcheurekdjian H, Lynch SV, Cabana M, Boushey HA. Microbial manipulation of immune function for asthma prevention: inferences from clinical trials. Proc Am Thorac Soc. 2007;4(3):277–282. doi: 10.1513/pats.200702-033AW.
    1. Wardwell LH, Huttenhower C, Garrett WS. Current concepts of the intestinal microbiota and the pathogenesis of infection. Curr Infect Dis Rep. 2011;13(1):28–34. doi: 10.1007/s11908-010-0147-7.
    1. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME. Probiotics and immunity. J Gastroenterol. 2009;44(1):26–46. doi: 10.1007/s00535-008-2296-0.
    1. Vliagoftis H, Kouranos VD, Betsi GI, Falagas ME. Probiotics for the treatment of allergic rhinitis and asthma: systematic review of randomized controlled trials. Ann Allergy Asthma Immunol. 2008;101(6):570–579. doi: 10.1016/S1081-1206(10)60219-0.
    1. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, Sogin ML, Jones WJ, Roe BA, Affourtit JP. et al.A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480–484. doi: 10.1038/nature07540.
    1. Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, Paludan-Muller G, Stokholm J, Smith B, Krogfelt KA. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128(3):646–652. doi: 10.1016/j.jaci.2011.04.060. e641-645.
    1. Round JL, Mazmanian SK. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol. 2009;9(5):313–323. doi: 10.1038/nri2515.
    1. Penders J, Thijs C, Vink C, Stelma FF, Snijders B, Kummeling I, van den Brandt PA, Stobberingh EE. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics. 2006;118(2):511–521. doi: 10.1542/peds.2005-2824.
    1. Adlerberth I, Wold AE. Establishment of the gut microbiota in Western infants. Acta Paediatr. 2009;98(2):229–238. doi: 10.1111/j.1651-2227.2008.01060.x.
    1. Ege MJ, Mayer M, Normand AC, Genuneit J, Cookson WO, Braun-Fahrlander C, Heederik D, Piarroux R, von Mutius E. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011;364(8):701–709. doi: 10.1056/NEJMoa1007302.
    1. Ly NP, Litonjua A, Gold DR, Celedon JC. Gut microbiota, probiotics, and vitamin D: interrelated exposures influencing allergy, asthma, and obesity? J Allergy Clin Immunol. 2011;127(5):1087–1094. doi: 10.1016/j.jaci.2011.02.015. quiz 1095–1086.
    1. Celedon JC, Weiss ST. Use of antibacterials in infancy: clinical implications for childhood asthma and allergies. Treat Respir Med. 2004;3(5):291–294. doi: 10.2165/00151829-200403050-00003.
    1. Forsythe P. Probiotics and lung diseases. Chest. 2011;139(4):901–908. doi: 10.1378/chest.10-1861.
    1. McLoughlin RM, Mills KH. Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J Allergy Clin Immunol. 2011;127(5):1097–1107. doi: 10.1016/j.jaci.2011.02.012. quiz 1108–1099.
    1. Issazadeh-Navikas S, Teimer R, Bockermann R. Influence of dietary components on regulatory T cells. Mol Med. 2012;18(1):95–110.
    1. Heydarian F, Kianifar HR, Ahanchian H, Khakshure A, Seyedi J, Moshirian D. A comparison between traditional yogurt and probiotic yogurt in non-inflammatory acute gastroenteritis. Saudi Med J. 2010;31(3):280–283.
    1. Johnston BC, Goldenberg JZ, Vandvik PO, Sun X, Guyatt GH. Probiotics for the prevention of pediatric antibiotic-associated diarrhea. Cochrane Database Syst Rev. 2011. p. CD004827.
    1. Wickens K, Black PN, Stanley TV, Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J. Probiotic Study G, Green C et al.A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol. 2008;122(4):788–794. doi: 10.1016/j.jaci.2008.07.011.
    1. Farid R, Ahanchian H, Jabbari F, Moghiman T. Effect of a New Synbiotic Mixture on Atopic Dermatitis in Children: a Randomized-Controlled Trial. Iran J Pediatr. 2011;21(2):225–230.
    1. Yao TC, Chang CJ, Hsu YH, Huang JL. Probiotics for allergic diseases: realities and myths. Pediatr Allergy Immunol. 2010;21(6):900–919. doi: 10.1111/j.1399-3038.2009.00955.x.
    1. Izumo T, Maekawa T, Ida M, Noguchi A, Kitagawa Y, Shibata H, Yasui H, Kiso Y. Effect of intranasal administration of Lactobacillus pentosus S-PT84 on influenza virus infection in mice. Int Immunopharmacol. 2010;10(9):1101–1106. doi: 10.1016/j.intimp.2010.06.012.
    1. Hojsak I, Snovak N, Abdovic S, Szajewska H, Misak Z, Kolacek S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, double-blind, placebo-controlled trial. Clin Nutr. 2010;29(3):312–316. doi: 10.1016/j.clnu.2009.09.008.
    1. Morrow LE, Kollef MH, Casale TB. Probiotic Prophylaxis of Ventilator-associated Pneumonia A Blinded, Randomized, Controlled Trial. Am J Respir Crit Care Med. 2010;182(8):1058–1064. doi: 10.1164/rccm.200912-1853OC.
    1. Hatakka K, Savilahti E, Ponka A, Meurman JH, Poussa T, Nase L, Saxelin M, Korpela R. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. Brit Med J. 2001;322(7298):1327–1329. doi: 10.1136/bmj.322.7298.1327.
    1. Hojsak I, Abdovic S, Szajewska H, Milosevic M, Krznaric Z, Kolacek S. Lactobacillus GG in the Prevention of Nosocomial Gastrointestinal and Respiratory Tract Infections. Pediatrics. 2010;125(5):E1171–E1177. doi: 10.1542/peds.2009-2568.
    1. de Vrese M, Winkler P, Rautenberg P, Harder T, Noah C, Laue C, Ott S, Hampe J, Schreiber S, Heller K. et al.Probiotic bacteria reduced duration and severity but not the incidence of common cold episodes in a double blind, randomized, controlled trial. Vaccine. 2006;24(44–46):6670–6674.
    1. Leyer GJ, Li SG, Mubasher ME, Reifer C, Ouwehand AC. Probiotic Effects on Cold and Influenza-Like Symptom Incidence and Duration in Children. Pediatrics. 2009;124(2):E172–E179. doi: 10.1542/peds.2008-2666.
    1. Winkler P, de Vrese M, Laue C, Schrezenmeir J. Effect of a dietary supplement containing probiotic bacteria plus vitamins and minerals on common cold infections and cellular immune parameters. Int J Clin Pharm Th. 2005;43(7):318–326.
    1. Hao Q, Lu Z, Dong BR, Huang CQ, Wu T. Probiotics for preventing acute upper respiratory tract infections. Cochrane Database Syst Rev. 2011;9:CD006895.
    1. Makino S, Ikegami S, Kume A, Horiuchi H, Sasaki H, Orii N. Reducing the risk of infection in the elderly by dietary intake of yoghurt fermented with Lactobacillus delbrueckii ssp. bulgaricus OLL1073R–1. Br J Nutr. 2010;104(7):998–1006. doi: 10.1017/S000711451000173X.
    1. Meydani SN, Ha WK. Immunologic effects of yogurt. Am J Clin Nutr. 2000;71(4):861–872.
    1. Merenstein D, Murphy M, Fokar A, Hernandez RK, Park H, Nsouli H, Sanders ME, Davis BA, Niborski V, Tondu F. et al.Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr. 2010;64(7):669–677. doi: 10.1038/ejcn.2010.65.
    1. de Moreno de LeBlanc A, Chaves S, Carmuega E, Weill R, Antoine J, Perdigon G. Effect of long-term continuous consumption of fermented milk containing probiotic bacteria on mucosal immunity and the activity of peritoneal macrophages. Immunobiology. 2008;213(2):97–108. doi: 10.1016/j.imbio.2007.07.002.
    1. Ares G, Gimenez A, Gambaro A. Influence of nutritional knowledge on perceived healthiness and willingness to try functional foods. Appetite. 2008;51(3):663–668. doi: 10.1016/j.appet.2008.05.061.
    1. Holzapfel WH, Haberer P, Geisen R, Bjorkroth J, Schillinger U. Taxonomy and important features of probiotic microorganisms in food and nutrition. Am J Clin Nutr. 2001;73(2 Suppl):365S–373S.
    1. Lomax AR, Calder PC. Prebiotics, immune function, infection and inflammation: a review of the evidence. Br J Nutr. 2009;101(5):633–658. doi: 10.1017/S0007114508055608.
    1. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial. Pediatrics. 2008;122(1):8–12. doi: 10.1542/peds.2007-1192.
    1. Rose MA, Stieglitz F, Koksal A, Schubert R, Schulze J, Zielen S. Efficacy of probiotic Lactobacillus GG on allergic sensitization and asthma in infants at risk. Clin Exp Allergy. 2010;40(9):1398–1405. doi: 10.1111/j.1365-2222.2010.03560.x.
    1. Del-Rio-Navarro BE, Espinosa Rosales F, Flenady V, Sienra-Monge JJ. Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev. 2006. p. CD004974.
    1. Weinberger M. Can we prevent exacerbations of asthma caused by common cold viruses? J Allergy Clin Immunol. 2010;126(4):770–771. doi: 10.1016/j.jaci.2010.08.019.
    1. Schaad UB. OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review. World J Pediatr. 2010;6(1):5–12. doi: 10.1007/s12519-010-0001-x.
    1. Razi CH, Harmanci K, Abaci A, Ozdemir O, Hizli S, Renda R, Keskin F. The immunostimulant OM-85 BV prevents wheezing attacks in preschool children. J Allergy Clin Immunol. 2010;126(4):763–769. doi: 10.1016/j.jaci.2010.07.038.
    1. Strickland DH, Judd S, Thomas JA, Larcombe AN, Sly PD, Holt PG. Boosting airway T-regulatory cells by gastrointestinal stimulation as a strategy for asthma control. Mucosal Immunol. 2011;4(1):43–52. doi: 10.1038/mi.2010.43.
    1. Rozy A, Chorostowska-Wynimko J. Bacterial immunostimulants–mechanism of action and clinical application in respiratory diseases. Pneumonol Alergol Pol. 2008;76(5):353–359.
    1. Holgate ST. Epithelium dysfunction in asthma. J Allergy Clin Immunol. 2007;120(6):1233–1244. doi: 10.1016/j.jaci.2007.10.025. quiz 1245–1236.
    1. Proud D. Role of rhinovirus infections in asthma. Asian Pac J Allergy Immunol. 2011;29(3):201–208.
    1. Koltsida O, Hausding M, Stavropoulos A, Koch S, Tzelepis G, Ubel C, Kotenko SV, Sideras P, Lehr HA, Tepe M. et -28A (IFN-lambda2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease. EMBO Mol Med. 2011;3(6):348–361. doi: 10.1002/emmm.201100142.
    1. Farr BM, Gwaltney JM, Adams KF, Hayden FG. Intranasal Interferon-Alpha-2 for Prevention of Natural Rhinovirus Colds. Antimicrob Agents Chemother. 1984;26(1):31–34. doi: 10.1128/AAC.26.1.31.
    1. Higgins PG, Alnakib W, Willman J, Tyrrell DAJ. Interferon-Beta-Ser as Prophylaxis against Experimental Rhinovirus Infection in Volunteers. J Interferon Res. 1986;6(2):153–159. doi: 10.1089/jir.1986.6.153.
    1. Phillpotts RJ, Scott GM, Higgins PG, Wallace J, Tyrrell DAJ, Gauci CL. An Effective Dosage Regimen for Prophylaxis against Rhinovirus Infection by Intranasal Administration of Huifn-Alpha-2. Antiviral Res. 1983;3(2):121–136. doi: 10.1016/0166-3542(83)90034-7.
    1. Miller EK, Hernandez JZ, Wimmenauer V, Shepherd BE, Hijano D, Libster R, Serra ME, Bhat N, Batalle JP, Mohamed Y. et al.A Mechanistic Role for Type III Interferon-lambda1 in Asthma Exacerbations Mediated by Human Rhinoviruses. Am J Respir Crit Care Med. 2011;185(5):508–516.
    1. Edwards MR, Johnston SL. Interferon-lambda as a new approach for treatment of allergic asthma? EMBO Mol Med. 2011;3(6):306–308. doi: 10.1002/emmm.201100143.
    1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. doi: 10.1056/NEJMra070553.
    1. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353–373. doi: 10.4065/81.3.353.
    1. Paul G, Brehm JM, Alcorn JF, Holguin F, Aujla SJ, Celedon JC. Vitamin d and asthma. Am J Respir Crit Care Med. 2012;185(2):124–132. doi: 10.1164/rccm.201108-1502CI.
    1. Biesalski HK. Vitamin D recommendations: beyond deficiency. Ann Nutr Metab. 2011;59(1):10–16. doi: 10.1159/000332066.
    1. Yim S, Dhawan P, Ragunath C, Christakos S, Diamond G. Induction of cathelicidin in normal and CF bronchial epithelial cells by 1,25-dihydroxyvitamin D(3) J Cyst Fibros. 2007;6(6):403–410. doi: 10.1016/j.jcf.2007.03.003.
    1. Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol. 2008;181(10):7090–7099.
    1. Vassallo MF, Camargo CA Jr. Potential mechanisms for the hypothesized link between sunshine, vitamin D, and food allergy in children. J Allergy Clin Immunol. 2010;126(2):217–222. doi: 10.1016/j.jaci.2010.06.011.
    1. Camargo CA Jr, Clark S, Kaplan MS, Lieberman P, Wood RA. Regional differences in EpiPen prescriptions in the United States: the potential role of vitamin D. J Allergy Clin Immunol. 2007;120(1):131–136. doi: 10.1016/j.jaci.2007.03.049.
    1. Osborne NJ, Ukoumunne OC, Wake M, Allen KJ. Prevalence of eczema and food allergy is associated with latitude in Australia. J Allergy Clin Immunol. 2012;129(3):865–867. doi: 10.1016/j.jaci.2012.01.037.
    1. Ginde AA, Mansbach JM, Camargo CA Jr. Vitamin D, respiratory infections, and asthma. Curr Allergy Asthma Rep. 2009;9(1):81–87. doi: 10.1007/s11882-009-0012-7.
    1. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128(6):3792–3798. doi: 10.1378/chest.128.6.3792.
    1. Jartti T, Ruuskanen O, Mansbach JM, Vuorinen T, Camargo CA Jr. Low serum 25-hydroxyvitamin D levels are associated with increased risk of viral coinfections in wheezing children. J Allergy Clin Immunol. 2010;126(5):1074–1076. doi: 10.1016/j.jaci.2010.09.004. 1076 e1071-1074.
    1. Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127(5):1294–1296. doi: 10.1016/j.jaci.2010.12.016.
    1. Hernando-Sastre V. Macrolide antibiotics in the treatment of asthma. An update. Allergol Immunopathol (Madr) 2010;38(2):92–98. doi: 10.1016/j.aller.2009.12.002.
    1. Jaffe A, Bush A. Anti-inflammatory effects of macrolides in lung disease. Pediatr Pulmonol. 2001;31(6):464–473. doi: 10.1002/ppul.1076.
    1. Good JT Jr, Rollins DR, Martin RJ. Macrolides in the treatment of asthma. Curr Opin Pulm Med. 2012;18(1):76–84. doi: 10.1097/MCP.0b013e32834daff8.
    1. Lin SJ, Lee WJ, Liang YW, Yan DC, Cheng PJ, Kuo ML. Azithromycin inhibits IL-5 production of T helper type 2 cells from asthmatic children. Int Arch Allergy Immunol. 2011;156(2):179–186. doi: 10.1159/000322872.
    1. Johnston SL. Macrolide antibiotics and asthma treatment. J Allergy Clin Immunol. 2006;117(6):1233–1236. doi: 10.1016/j.jaci.2006.03.035.
    1. Gielen V, Johnston SL, Edwards MR. Azithromycin induces anti-viral responses in bronchial epithelial cells. Eur Respir J. 2010;36(3):646–654. doi: 10.1183/09031936.00095809.
    1. Asada M, Yoshida M, Suzuki T, Hatachi Y, Sasaki T, Yasuda H, Nakayama K, Nishimura H, Nagatomi R, Kubo H. et al.Macrolide antibiotics inhibit respiratory syncytial virus infection in human airway epithelial cells. Antiviral Res. 2009;83(2):191–200. doi: 10.1016/j.antiviral.2009.05.003.
    1. Tahan F, Ozcan A, Koc N. Clarithromycin in the treatment of RSV bronchiolitis: a double-blind, randomised, placebo-controlled trial. Eur Respir J. 2007;29(1):91–97.
    1. Miller EK, Edwards KM, Weinberg GA, Iwane MK, Griffin MR, Hall CB, Zhu Y, Szilagyi PG, Morin LL, Heil LH. et al.A novel group of rhinoviruses is associated with asthma hospitalizations. J Allergy Clin Immunol. 2009;123(1):98–104 e101. doi: 10.1016/j.jaci.2008.10.007.
    1. Khetsuriani N, Lu X, Teague WG, Kazerouni N, Anderson LJ, Erdman DD. Novel human rhinoviruses and exacerbation of asthma in children. Emerg Infect Dis. 2008;14(11):1793–1796. doi: 10.3201/eid1411.080386.
    1. Harris JM 2nd, Gwaltney JM Jr. Incubation periods of experimental rhinovirus infection and illness. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1996;23(6):1287–1290. doi: 10.1093/clinids/23.6.1287.
    1. Staunton DE, Merluzzi VJ, Rothlein R, Barton R, Marlin SD, Springer TA. A cell adhesion molecule, ICAM-1, is the major surface receptor for rhinoviruses. Cell. 1989;56(5):849–853. doi: 10.1016/0092-8674(89)90689-2.
    1. Hofer F, Gruenberger M, Kowalski H, Machat H, Huettinger M, Kuechler E, Blaas D. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci U S A. 1994;91(5):1839–1842. doi: 10.1073/pnas.91.5.1839.
    1. Rankl C, Kienberger F, Wildling L, Wruss J, Gruber HJ, Blaas D, Hinterdorfer P. Multiple receptors involved in human rhinovirus attachment to live cells. Proc Natl Acad Sci U S A. 2008;105(46):17778–17783. doi: 10.1073/pnas.0806451105.
    1. Jang YJ, Wang JH, Kim JS, Kwon HJ, Yeo NK, Lee BJ. Levocetirizine inhibits rhinovirus-induced ICAM-1 and cytokine expression and viral replication in airway epithelial cells. Antiviral Res. 2009;81(3):226–233. doi: 10.1016/j.antiviral.2008.12.001.
    1. Prasad AS, Beck FW, Bao B, Snell D, Fitzgerald JT. Duration and severity of symptoms and levels of plasma interleukin-1 receptor antagonist, soluble tumor necrosis factor receptor, and adhesion molecules in patients with common cold treated with zinc acetate. J Infect Dis. 2008;197(6):795–802. doi: 10.1086/528803.
    1. Fang F, Yu M. Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196. J Antimicrob Chemother. 2004;53(1):23–25.
    1. Turner RB, Wecker MT, Pohl G, Witek TJ, McNally E, St George R, Winther B, Hayden FG. Efficacy of tremacamra, a soluble intercellular adhesion molecule 1, for experimental rhinovirus infection - A randomized clinical trial. Jama-J Am Med Assoc. 1999;281(19):1797–1804. doi: 10.1001/jama.281.19.1797.
    1. Thibaut HJ, De Palma AM, Neyts J. Combating enterovirus replication: state-of-the-art on antiviral research. Biochem Pharmacol. 2012;83(2):185–192. doi: 10.1016/j.bcp.2011.08.016.
    1. Hayden FG, Turner RB, Gwaltney JM, Chi-Burris K, Gersten M, Hsyu P, Patick AK, Smith GJ, Zalman LS. Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers. Antimicrob Agents Chemother. 2003;47(12):3907–3916. doi: 10.1128/AAC.47.12.3907-3916.2003.
    1. Schubert S, Furste JP, Werk D, Grunert HP, Zeichhardt H, Erdmann VA, Kurreck J. Gaining target access for deoxyribozymes. J Mol Biol. 2004;339(2):355–363. doi: 10.1016/j.jmb.2004.03.064.
    1. Stone JK, Rijnbrand R, Stein DA, Ma Y, Yang Y, Iversen PL, Andino R. A morpholino oligomer targeting highly conserved internal ribosome entry site sequence is able to inhibit multiple species of picornavirus. Antimicrob Agents Chemother. 2008;52(6):1970–1981. doi: 10.1128/AAC.00011-08.
    1. Phipps KM, Martinez A, Lu J, Heinz BA, Zhao G. Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism. Antiviral Res. 2004;61(1):49–55. doi: 10.1016/j.antiviral.2003.08.005.
    1. Stensballe LG, Ravn H, Kristensen K, Agerskov K, Meakins T, Aaby P, Simoes EA. Respiratory syncytial virus neutralizing antibodies in cord blood, respiratory syncytial virus hospitalization, and recurrent wheeze. J Allergy Clin Immunol. 2009;123(2):398–403. doi: 10.1016/j.jaci.2008.10.043.
    1. Hansbro NG, Horvat JC, Wark PA, Hansbro PM. Understanding the mechanisms of viral induced asthma: new therapeutic directions. Pharmacol Ther. 2008;117(3):313–353. doi: 10.1016/j.pharmthera.2007.11.002.
    1. Simoes EA, Groothuis JR, Carbonell-Estrany X, Rieger CH, Mitchell I, Fredrick LM, Kimpen JL. Palivizumab prophylaxis, respiratory syncytial virus, and subsequent recurrent wheezing. J Pediatr. 2007;151(1):34–42. doi: 10.1016/j.jpeds.2007.02.032. 42 e31.
    1. Wu H, Pfarr DS, Johnson S, Brewah YA, Woods RM, Patel NK, White WI, Young JF, Kiener PA. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract. J Mol Biol. 2007;368(3):652–665. doi: 10.1016/j.jmb.2007.02.024.
    1. Shadman KA, Wald ER. A review of palivizumab and emerging therapies for respiratory syncytial virus. Expert Opin Biol Ther. 2011;11(11):1455–1467. doi: 10.1517/14712598.2011.608062.
    1. Carbonell-Estrany X, Simoes EA, Dagan R, Hall CB, Harris B, Hultquist M, Connor EM, Losonsky GA. Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial. Pediatrics. 2010;125(1):e35–e51. doi: 10.1542/peds.2008-1036.
    1. Bardin PG. Vaccination for asthma exacerbations. Intern Med J. 2004;34(6):358–360. doi: 10.1111/j.1445-5994.2004.00603.x.
    1. Rosenthal LA, Avila PC, Heymann PW, Martin RJ, Miller EK, Papadopoulos NG, Peebles RS, Gern JE, Immunol AAAA. Viral respiratory tract infections and asthma: The course ahead. J Allergy Clin Immun. 2010;125(6):1212–1217. doi: 10.1016/j.jaci.2010.04.002.
    1. Bizzintino J, Lee WM, Laing IA, Vang F, Pappas T, Zhang G, Martin AC, Khoo SK, Cox DW, Geelhoed GC. et al.Association between human rhinovirus C and severity of acute asthma in children. Eur Respir J. 2011;37(5):1037–1042. doi: 10.1183/09031936.00092410.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren